Vijay Kumar Evercore ISI Group Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
91
Avg Return
Past Year
Past Year
1%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
71.8%
Neutral
28.2%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Financials
Healthcare
Industrials
Technology
Financials
Banks - Regional
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Medical Devices
Medical Instruments & Supplies
Industrials
Integrated Freight & Logistics
Technology
Scientific & Technical Instruments
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $34 |
87%
upside
| 3 | -8.3% |
0
%
| 27 Feb ‘26 3 months ago |
|
|
|
Outperform
Maintained
| $360 |
13%
upside
| 3 | +8.6% |
0
%
| 26 Feb ‘26 3 months ago |
|
|
|
In-Line
Maintained
| $65 |
12%
upside
| 4 | – |
–
| 5 Feb ‘26 4 months ago |
|
|
|
Outperform
Maintained
| $98 |
51%
upside
| 3 | +1.3% |
0
%
| 5 Feb ‘26 4 months ago |
|
|
|
Outperform
Maintained
| $96 |
105%
upside
| 3 | -11% |
0
%
| 5 Feb ‘26 4 months ago |
|
|
|
Outperform
Maintained
| $45 |
96%
upside
| 4 | -21% |
0
%
| 5 Feb ‘26 4 months ago |
|
|
|
Outperform
Maintained
| $52 |
36%
downside
| 2 | +22% |
0
%
| 3 Feb ‘26 4 months ago |
|
|
|
Outperform
Maintained
| $118 |
17%
upside
| 3 | -3.4% |
0
%
| 3 Feb ‘26 4 months ago |
|
|
|
In-Line
Maintained
| $550 |
32%
upside
| 4 | – |
–
| 23 Jan ‘26 4 months ago |
|
|
|
Outperform
Maintained
| $138 |
56%
upside
| 6 | -2.1% |
0
%
| 23 Jan ‘26 4 months ago |
|
|
|
Outperform
Maintained
| $223 |
21%
downside
| 3 | +17% |
0
%
| 13 Jan ‘26 5 months ago |
|
|
|
In-Line
Downgraded
| $78 |
3%
upside
| 4 | +11% |
0
%
| 5 Jan ‘26 5 months ago |
|
|
|
In-Line
Downgraded
| $105 |
0%
upside
| 5 | +26% |
0
%
| 5 Jan ‘26 5 months ago |
|
|
|
In-Line
Downgraded
| $18 |
20%
upside
| 5 | +9.6% |
0
%
| 5 Jan ‘26 5 months ago |
|
|
|
In-Line
Downgraded
| $12 |
24%
upside
| 3 | +0.45% |
0
%
| 5 Jan ‘26 5 months ago |
|
|
|
Outperform
Upgraded
| $120 |
36%
upside
| 3 | +4.3% |
0
%
| 5 Jan ‘26 5 months ago |
|
|
|
Outperform
Upgraded
| $210 |
85%
upside
| 3 | -34% |
0
%
| 5 Jan ‘26 5 months ago |
|
|
|
Outperform
Upgraded
| $160 |
23%
upside
| 5 | -19% |
0
%
| 5 Jan ‘26 5 months ago |
|
|
|
Outperform
Maintained
| $405 |
32%
upside
| 4 | -1.7% |
0
%
| 31 Oct ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $142 |
15%
downside
| 3 | +7.6% |
0
%
| 31 Oct ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $92 |
7%
upside
| 4 | +4.5% |
0
%
| 31 Oct ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $590 |
25%
upside
| 3 | +4.5% |
0
%
| 7 Oct ‘25 8 months ago |
|
|
|
Outperform
Maintained
| $1,400 |
21%
upside
| 3 | +0.69% |
0
%
| 7 Oct ‘25 8 months ago |
|
|
|
Outperform
Maintained
| $245 |
35%
upside
| 2 | -1.9% |
0
%
| 7 Oct ‘25 8 months ago |
|
|
|
Outperform
Maintained
| $31 |
49%
upside
| 2 | -24% |
0
%
| 7 Oct ‘25 8 months ago |
|